Pierre Sabouret/LinkedIn
Jan 4, 2026, 10:28
5 Useful Papers in Clinical Practice, Suggested by Pierre Sabouret
Pierre Sabouret, Member of the Executive Committee for Education at European Atherosclerosis Society, shared on LinkedIn:
“2025 also was a productive year. We published 5 MA which may be useful in clinical practice.
1. Best antithrombotic regimen after LAAC
2. Optimal long term treatment after DVT PE
3. Comparison of strategies in patients with CCS and AF
4. Magnitude of benefits in HBP of the new ASI (Aldosterone Specific Inhibitors)
5. CVR in Autoimmune Diseases.
Thanks to all coauthors for the huge efforts”
Stay updated with Hemostasis Today.
-
Sep 8, 2026, 11:15Andreas Tridimas: Atherosclerosis Is Greyer Than We Admit
-
Sep 8, 2026, 10:59Eman M. Elsabbagh: Pediatric Nonmalignant HCT Enters the Era of Precision Conditioning and Gene Therapy
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome